221 related articles for article (PubMed ID: 18335520)
1. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.
Shaikh S; Nicholson LF
J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520
[TBL] [Abstract][Full Text] [Related]
2. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
Lev N; Melamed E; Offen D
Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
[TBL] [Abstract][Full Text] [Related]
3. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.
Matsuzaki M; Hasegawa T; Takeda A; Kikuchi A; Furukawa K; Kato Y; Itoyama Y
Brain Res; 2004 Apr; 1004(1-2):83-90. PubMed ID: 15033422
[TBL] [Abstract][Full Text] [Related]
4. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
5. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration.
Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
Neuroscience; 2005; 133(1):117-35. PubMed ID: 15893636
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.
Meredith GE; Halliday GM; Totterdell S
Parkinsonism Relat Disord; 2004 Jun; 10(4):191-202. PubMed ID: 15120093
[TBL] [Abstract][Full Text] [Related]
7. N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.
Choi YG; Lim S
Biochimie; 2010 Oct; 92(10):1379-86. PubMed ID: 20624443
[TBL] [Abstract][Full Text] [Related]
8. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
Bosco DA; Fowler DM; Zhang Q; Nieva J; Powers ET; Wentworth P; Lerner RA; Kelly JW
Nat Chem Biol; 2006 May; 2(5):249-53. PubMed ID: 16565714
[TBL] [Abstract][Full Text] [Related]
10. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.
Hasegawa T; Matsuzaki M; Takeda A; Kikuchi A; Akita H; Perry G; Smith MA; Itoyama Y
Brain Res; 2004 Jul; 1013(1):51-9. PubMed ID: 15196967
[TBL] [Abstract][Full Text] [Related]
11. Role of advanced glycation on aggregation and DNA binding properties of α-synuclein.
Padmaraju V; Bhaskar JJ; Prasada Rao UJ; Salimath PV; Rao KS
J Alzheimers Dis; 2011; 24 Suppl 2():211-21. PubMed ID: 21441659
[TBL] [Abstract][Full Text] [Related]
12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
13. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells.
Sung JY; Lee HJ; Jeong EI; Oh Y; Park J; Kang KS; Chung KC
Neurosci Lett; 2007 Apr; 416(3):289-93. PubMed ID: 17337120
[TBL] [Abstract][Full Text] [Related]
15. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
Häbig K; Walter M; Stappert H; Riess O; Bonin M
Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
[TBL] [Abstract][Full Text] [Related]
16. [The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro].
Chen T; Tang BS; Liao XP; Yan XX; Zhang RX; Zhang YH; Tang JG; Cao L; Guo JF; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):19-22. PubMed ID: 16456779
[TBL] [Abstract][Full Text] [Related]
17. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
18. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.
Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A
Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.
Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P
Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
